Compare ARK Genomic Revolution ETF (ARKG) vs Vanguard Total Bond Market Index Fund ETF (BND) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Vanguard Total Bond Market Index Fund ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Vanguard Total Bond Market Index Fund ETF trades at $72.74. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Vanguard Total Bond Market Index Fund ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | BND | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $75.17 |
52-Week Low | $23.09 | $72.45 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
BND trades at $72.77, down 0.08% on the day, with a bearish technical signal driven by moving averages. Recent news highlights its role as a core bond ETF for stability and income, with comparisons to peers like iShares IGIB focusing on yield and cost advantages. The fund's dividend history shows consistent payouts, supporting its appeal for income-focused investors amid market volatility.
The outlook for BND is cautious due to bearish technicals and interest rate risks, but its low-cost, diversified bond exposure offers defensive appeal. Key risks include duration sensitivity to Fed hikes, while institutional inflows signal confidence in fixed income. Investors should weigh yield stability against potential price declines if rates rise further.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Vanguard Total Bond Market Index Fund ETF
This index measures the performance of a wide spectrum of public, investment-grade, taxable, fixed income securities in the US, including government, corporate, and international dollar-denominated bonds, as well as mortgage-backed and asset-backed securities-all with maturities of more than 1 year. All of the fund's investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the index.
Read more on BND →
